Glucose-Dependent Insulinotropic Polypeptide Induced Growth Hormone Secretion in Acromegaly

Endocrine Journal

Volumn 50, Issue 5, 2003, Pages 643-650

  Umahara, Mitsuhiko ^a   Okada, Shuichi ^b   Ohshima, Kihachi ^c   Mori, Masatomo ^b  

^a Nanokaichi Municipal Hospital   (Japan)

^b GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c GUNMA UNIVERSITY   (Japan)

Author keywords

Acromegaly; GH; GIP

Indexed keywords

GASTRIC INHIBITORY POLYPEPTIDE; GLUCOSE; GROWTH HORMONE; PEPTIDE DERIVATIVE; POLYPEPTIDE; UNCLASSIFIED DRUG;

ACROMEGALY; ADULT; AGED; ARTICLE; BRAIN SURGERY; CASE REPORT; FEMALE; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; HUMAN; HYPOPHYSIS ADENOMA; ORAL GLUCOSE TOLERANCE TEST;

ACROMEGALY; AGED; FEMALE; GASTRIC INHIBITORY POLYPEPTIDE; GLUCOSE TOLERANCE TEST; HUMAN GROWTH HORMONE; HUMANS; INJECTIONS, INTRAVENOUS; MIDDLE AGED; POSTPRANDIAL PERIOD;

EID: 0344010159     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.50.643     Document Type: Article

References (33)

1. Roth J, Glick SM, Yallow RS, Berson SA (1963) Secretion of human growth hormone: physiologic and experimental modification. Metabolism 12: 577-579.
2. Glick SM, Roth J, Yallow RS, Berson SA (1965) The regulation of growth hormone secretion. Recent Prog Horm Res 21: 241-243.
3. Hartog JM, Gaafar MA, Meisser B, Fraser R (1964) Immunoassay of serum growth hormone in the diagnosis of acromegalic patients. Br Med J 2: 1229-1232.
4. Earll JM, Sparks LL, Forsham PH (1964) Glucose suppression of serum growth hormone in the diagnosis of acromegaly. JAMA 201: 628-630.
5. Melmed S (1990) Acromegaly. N Engl J Med 322: 966-977.
6. Ensinck JW, D'Alessio DA (1992) The enteroinsular axis revisited: A novel role for incretin. N Engl J Med 326: 1352-1353.
7. McGuigan JE (1989) Hormones of the gastrointestinal tract. In: DeGroot LJ, Besser GF Jr, Marshall JC, et al. (eds) Endocrinology. 2nd ed. Vol. 3. WB Saunders, Philadelphia, 2741-2768.
8. Usdin TB, Mezey E, Button DC, Brownstein MJ, Bonner TI (1993) Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal polypeptide receptor family, is widely distributed in peripheral organs and brain. Endocrinology 133: 2861-2879.
9. Lacroix A, Bolte E, Tremblay J, et al. (1992) Gastric inhibitory polypeptide-dependent cortisol hypersecretion-A new cause of Cushing's syndrome. N Engl J Med 327: 974-980.
10. Reznik Y, Allali-Zerah V, Chayvialle JA, et al. (1992) Food-dependent Cushing's syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory polypeptide. N Engl J Med 327: 981-986.
11. + on GRF-induced GH secretion from rat pituitary cell. Am J Physiol 256: C712-718.
12. Thaomer MO, Vance ML, Hoorvath E, Kovacs K (1992) The anterior pituitary: regulation of growth hormone secretion. In: Wilson JD, Forster DW (eds) Textbook of endocrinology, 8th ed. WB Saunders, Philadelphia, 230-234.
13. Shibasaki T, Masude A, Hotta M, et al. (1989) Effect of ingestion of glucose on GH and TSH secretion: Evidence for stimulation of somatostatin release from the hypothalamus by acute hyperglycemia in normal man and its impairment in acromegalic patients. Life Sci 44: 431-438.
14. Masuda A, Shibasaki T, Nakahara M, et al. (1985) The effect of glucose on growth hormone (GH)-releasing hormone-mediated G secretion in man. J Clin Endocrinol Metab 60: 523-526.
15. Davies RR, Turner S, Johnston DG (1984) Oral glucose inhibits growth hormone secretion induced by human pancreatic growth hormone releasing factor 1-44 in normal man. Clin Endocrinol (Oxf) 21: 477-481.
16. Boizel R, Halimi S, Labat F, Cohen R, Bachelot I (1987) Acromegaly due to a growth hormone-releasing hormone-secreting bronchial carotid tumor: Further information on abnormal responsiveness of the somatotroph cells and their recovery after successful treatment. J Clin Endocrinol Metab 64: 304-308.
17. Molitch ME (1988) Acromegaly. In: Collu R, Brown GM, Van Loon GR (eds) Clinical neuroendocrinology 1st ed. Blackwell Scientific Publications, Boston, 189-227.
18. Kato Y, Shimatsu A, Matsushita N, Ohta H, Imura H (1984) Role of vasoactive intestinal polypeptide (VIP) in regulating the pituitary function in man. Peptides 5: 389-394.
19. Matsushita N, Kato Y, Katakami H, Shimatsu A, Yanaihara N, Imura H (1981) Stimulation of growth hormone release by vasoactive intestinal polypeptide from human pituitary adenomas in vitro. J Clin Endocrinol Metab 53: 1297-1300.
20. Chihara K, Iwasaki J, Minamitani N, et al. (1982) Effect of vasoactive intestinal polypeptide on growth hormone secretion in perifused acromegalic pituitary adenoma tissue. J Clin Endocrinol Metab 54: 773-779.
21. Watanabe H, Sasaki S, Sone K, Takebe K (1991) Paradoxical response of growth hormone to peptide histidine methionine in acromegaly: comparison with the effects of thyrotropin releasing hormone and vasoactive intestinal peptide. J Clin Endocrinol Metab 72: 982-985.
22. Ottlecz A, Samson WK, McCann SM (1985) The effect of gastric inhibitory polypeptide (GIP) on the release of anterior pituitary hormones. Peptides 6: 115-119.
23. Vijayan E, Samson WK, Said SI, Mccann SM (1979) Vasoactive intestinal polypeptide: Evidence for hypothalamic site of action to release growth hormone, luteinizing hormone, and prolactin in conscious ovariectomized rats. Endocrinology 104: 53-57.
24. Fialkow PJ (1986) Clonal origin of human tumors. Biochem Biophys Acta 458: 283-321.
25. Knudson AG (1973) Mutation and human cancer. Adv Cancer Res 17: 317-352.
26. Emami S, Chaster E, Bodere H, Gespach C, Bataille D, Rosselin G (1986) Functional receptors for VIP, GIP, glucagon-29 and -37 in the HGT-1 human gastric cancer cell line. Peptides 7 Suppl 1: 121-127.
27. Amiranoff B, Vauclin JN, Laburthe M (1985) Interaction of gastric inhibitory polypeptide (GIP) with the insulin-secretic-beta cell line, In III: characteristics of GIP binding sites. Life Sci 36: 807-813.
28. Amiranoff B, Vauclin JN, Laburthe M (1984) Functional GIP receptor in hamster pancreatic beta cell line, In III: Specific binding and biological effects. Biochem Biophys Res Commun 123: 671-676.
29. Comblath M, Parker ML, Reisner SH, Forbes AE, Daughaday WH (1965) Secretion and metabolism of growth hormone in premature and full-term infants. J Clin Endocrinol Metab 25: 209-218.
30. Evain-Brion D, Gamier P, Schmpff RM, Chaussain JL, Job JC (1983) Growth hormone response to thyrotropin-releasing hormone and oral glucose-loading tests in tall children and adolescents. J Clin Endocrinol Metab 56: 429-432.
31. Pieters GFFM, Smals AGH, Kloppenborg PWC (1980) Defective suppression of growth hormone after oral glucose loading in adolescence. J Clin Endocrinol Metab 51: 265-270.
32. Hattori N, Shimatsu A, Kato Y, et al. (1990) Growth hormone responses to oral glucose loading measured by highly sensitive enzyme immunoassay in normal subjects and patients with glucose intolerance and acromegaly. J Clin Endocrinol Metab 70: 771-776.
33. Bertagna X (1992) New causes of Cushing's syndrome. N Engl J Med 327: 1024-1025.